Pioneer Study: Seniors Paid More for Key Drugs Despite Federal Price Controls
Out-of-pocket costs rose in 2025 for widely used Medicare drugs targeted under Inflation Reduction Act BOSTON – Many Medicare seniors paid higher out-of-pocket costs in 2025 for widely used prescription drugs—despite a federal law intended to lower…
